These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17436358)

  • 1. Results of forty years Yellow Card reporting for commonly used perioperative analgesic drugs.
    Richardson J; Holdcroft A
    Pharmacoepidemiol Drug Saf; 2007 Jun; 16(6):687-94. PubMed ID: 17436358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paediatric adverse drug reaction reporting: understanding and future directions.
    Carleton BC; Smith MA; Gelin MN; Heathcote SC
    Can J Clin Pharmacol; 2007; 14(1):e45-57. PubMed ID: 17297195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneously reported fatal suspected adverse drug reactions: a 10-year survey from Sweden.
    Wester K; Jönsson A; Spigset O; Hägg S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):173-80. PubMed ID: 16739241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and characteristics of adverse drug reactions in neurosurgical intensive care patients.
    Smith KM; Jeske CS; Young B; Hatton J
    Neurosurgery; 2006 Mar; 58(3):426-33; discussion 426-33. PubMed ID: 16528181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Thai anesthesia incident monitoring study of perioperative allergic reactions: an analysis of 1996 incidents reports.
    Lapisatepun W; Charuluxananan S; Kusumaphanyo C; Ittichaikulthol W; Suksompong S; Ratanachai P
    J Med Assoc Thai; 2008 Oct; 91(10):1524-30. PubMed ID: 18972895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
    Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects of neuromuscular blocking agents based on yellow card reporting in the U.K.: are there differences between males and females?
    Light KP; Lovell AT; Butt H; Fauvel NJ; Holdcroft A
    Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):151-60. PubMed ID: 16395661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of electronic reporting to aid surveillance of ADRs in children: a proof of concept study.
    Lynn RM; Riding K; McIntosh N
    Arch Dis Child; 2010 Apr; 95(4):262-5. PubMed ID: 20335236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database.
    Durrieu G; Olivier P; Bagheri H; Montastruc JL;
    Fundam Clin Pharmacol; 2007 Oct; 21(5):555-8. PubMed ID: 17868209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reporting of adverse drug reactions in Iceland in 1999 to 2004].
    Jóhannsson M; Agústsdóttir E
    Laeknabladid; 2006 Apr; 92(4):283-7. PubMed ID: 16582456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspective.
    Tremlett HL; Oger J
    Mult Scler; 2008 Jan; 14(1):94-105. PubMed ID: 17881392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneously reported adverse reactions in association with complementary and alternative medicine substances in Sweden.
    Jacobsson I; Jönsson AK; Gerdén B; Hägg S
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1039-47. PubMed ID: 19650152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals.
    McLernon DJ; Bond CM; Hannaford PC; Watson MC; Lee AJ; Hazell L; Avery A;
    Drug Saf; 2010 Sep; 33(9):775-88. PubMed ID: 20701410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of antimicrobial-related adverse drug reactions in hospitalized patients.
    Sun HY; Chen YC; Wang YW; Gau CS; Chang SC
    J Microbiol Immunol Infect; 2008 Apr; 41(2):151-9. PubMed ID: 18473103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
    Jha N; Bajracharya O; Namgyal T
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of adverse drug reactions due to cancer chemotherapy in a tertiary care teaching hospital in Nepal.
    Mallik S; Palaian S; Ojha P; Mishra P
    Pak J Pharm Sci; 2007 Jul; 20(3):214-8. PubMed ID: 17545106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reactions of psycopharmacs.
    Skvrce NM; Arapović S; Krnić D; Sarinić VM; Zezelić S; Bagatin K; Leventić J; Tomić S
    Psychiatr Danub; 2010 Sep; 22(3):441-5. PubMed ID: 20856189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database.
    Shalviri G; Mohammad K; Majdzadeh R; Gholami K
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1136-40. PubMed ID: 17705214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005.
    Moore TJ; Cohen MR; Furberg CD
    Arch Intern Med; 2007 Sep; 167(16):1752-9. PubMed ID: 17846394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.